Objectives: Recent studies have shown that patients with uncomplicated acute type B aortic dissection (uATBAD) who have enlarged descending thoracic aortic diameters are at high risk of developing complications. This study aimed to determine the effect of maximum ascending aortic diameter and area on outcomes in patients with uATBAD.
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Objectives: This study assessed in-hospital mortality and midterm results of emergency thoracic endovascular aortic repair (TEVAR) stent grafting for patients with life-threatening complications of acute type B aortic dissections (acTBD).
Methods: Between March 2001 and Sept 2016, 53 patients (38 men; mean age, 55 6 13) with an acTBD were treated with TEVAR for malperfusion (55%), aortic rupture (15%), or persistent untreatable pain (30%) as a sign of pending rupture. Four patients (8%) had undergone previous aortic surgery.
Results: Technical success (coverage of the primary tear site) was achieved in 48 patients (91%). Overall hospital mortality rate was 9% (n ¼ 5). Causes of death were rupture during the procedure or on the first postinterventional day in two patients and redissection (ascending aorta n ¼ 2, descending aorta n ¼ 1) with consequent aortic rupture after TEVAR in the remaining three. Permanent neurologic dysfunction occurred in 3 patients (stroke n ¼ 1, paraplegia n ¼ 2). Nineteen patients (36%) developed early endoleaks (type Ia, n ¼ 5; type Ib, n ¼ 11; type II, n ¼ 2; type Ib plus II, n ¼ 1) and were observed throughout the postinterventional period. These seven patients (37%) needed secondary endovascular intervention (n ¼ 3) or conventional surgery (n ¼ 4) due to aortic progression (mean interval after procedure 92 6 56 months). Secondary endoleaks were observed in nine patients with consequent reintervention in three patients. The actuarial survival was 88%, 76%, and 58% at 1, 5, and 10 years, respectively. Freedom from treatment failure at 1, 5, and 10 years (including reintervention, aortic rupture, device-related complications, aortic-related death, or sudden, unexplained late death) was 76 %, 74%, and 74%, respectively.
Conclusions: TEVAR in the treatment of acute complicated type B aortic dissection proves to be an excellent treatment modality in this high risk patient cohort. Refinements, especially in stent design and application, may further reduce the rate of endoleaks and improve the prognosis of patients in this life-threatening situation. Objectives: This study evaluated the outcomes from a postmarket registry of the Zenith Spiral-Z AAA Iliac Leg Graft (Spiral-Z leg graft) with a continuous, spiral nitinol stent that was designed for improved conformability, kink, and migration resistance.
Methods: This prospective, multicenter registry was designed to evaluate the outcomes of the Spiral-Z leg graft in up to 600 patients who underwent EVAR at up to 30 sites in the United States and Canada. Patients were enrolled between March 2012 and March 2015. Main study outcomes were iliac limb occlusion, limb-related reintervention, limb-related endoleak, component separation, and device integrity. Short-term data were collected during an interval of 1 to 6 months with longer-term data collected at 12 months.
Results: Among 592 study patients (mean age 74 6 8 years; 87% male; 26% with aortoiliac aneurysm), Spiral-Z leg grafts were placed in 1151 limbs with subsequent Spiral-Z leg extensions used in 102 limbs. The mean iliac diameters were 9 6 4 mm (left) and 9 6 3 mm (right), and moderate/severe occlusive disease, calcification, and vessel tortuosity were present in 14%, 25%, and 36% (left) and 16%, 25%, and 34% (right), respectively, of iliac arteries. Adjunctive intraoperative iliac artery procedures (iliac artery angioplasty and/or stent placement) were performed in 119 patients (20%; bilateral in 57 patients). Mortality within 30 days was 1.5% (9 of 592); cumulative mortality at 365 days was 5.9% (35 of 592). There were no aortic ruptures, but one open conversion (0.2%). Limb occlusions occurred in 11 patients (1.9%; 3 within and 8 after 30 days; all unilateral; none had received procedural iliac artery adjuncts at implantation); of these, seven patients underwent reinterventions. An additional eight patients underwent limb-related reinterventions for nonocclusive kink, compression, or thrombus (6 within and 2 after 30 days). In total, 14 patients (2.4%) underwent 15 limb-related reinterventions (7 for occlusions and 8 for nonocclusive causes); eight of these 15 reinterventions occurred within 1 week of the index procedure. One case of distal type I endoleak and device migration (>10 mm) of a right iliac leg component was noted during longer-term follow-up. No other limb-related endoleak, migration, component separation, or stent fracture was reported during a mean follow-up of 10.8 6 5.6 months.
Conclusions: Results from this postmarket registry under routine clinical care demonstrate infrequent limb occlusions and limb-related reintervention, supporting the excellent performance of the Spiral-Z leg graft. Results: Sixty-two patients (74% male; age, 72 6 7 years) with 1 type I (1%), 14 type II (23%), 24 type III (39%), and 23 type IV (37%) TAAAs underwent FB-EVAR. The mean TAAA diameter and total TVV were 65 6 13 mm and 226, respectively. Thirty patients (48%) were clustered in GA and 32 (52%) in GB. Patients in GA and GB had similar preoperative clinical and morphologic characteristics, except for female gender (GA: 40% vs GB: 13%; P ¼ .02). TS was 92% (GA: 90% vs GB: 94%; P ¼ .6), SCI was 5% (GA: 10% vs GB: 0%; P ¼ .1), and 30-day mortality was 5% (GA: 10% vs GB: 0%; P ¼ .1). The mean follow-up was 17 6 11 months with a total survival of 86%, 80%, and 60% at 6, 12, and 24 months, respectively, and no differences in the two groups (GA: 83%, 83%, and 67% vs GB: 88%, 78%, and 55% respectively; P ¼ .96). There was no late TAAA-related mortality. TVV patency was 91%, 91%, and 91% at 6, 12, and 24 months, respectively (GA: 87%, 87%, and 87% vs GB: 95%; 95%, and 95%; P ¼ .25). Freedom from reinterventions was 90%, 87%, and 87%, at 6, 12, and 24 months, respectively, and was significantly lower in GA compared with GB (GA: 83%, 76%, and 76% vs GB: 96%, 96%, and 96%, respectively; P ¼ .002).
Conclusions: POR does not significantly affect the early outcomes of FB-EVAR in TAAA, with encouraging results in terms of TS, SCI, mortality, and a lower reintervention rate at midterm follow-up.
Author Disclosures: S. Ancetti: Nothing to disclose; C. Mascoli: Nothing to disclose; G. Faggioli: Nothing to disclose; E. Gallitto: Nothing to disclose; M. Gargiulo: Nothing to disclose; M. Longhi: Nothing to disclose; R. Pini: Nothing to disclose; A. Stella: Nothing to disclose. Objectives: Aortic dissections, which affect 12,000 new patients per year in the United States, are associated with significant morbidity and mortality. The etiology is unclear, but the underlying pathophysiology may be related to hypertension-induced injury in the setting of an aorta that has lost compliance. Aortic stent grafts can effectively treat acute complications of aortic dissection. Stent grafts are essentially rigid tubes, and after implantation, pressure with systole has to be dissipated by the residual aorta proximal and distal to the stent graft. Our group postulated that the rigid stent itself may exacerbate pressure on the residual aorta. These regions of native aorta proximal to the stent graft are required to limit pressure differences, inducing larger stresses and increasing the potential of aortic tearing. Stent graft-induced new tears (SINE) have been recorded in 30% of patients treated with a stent graft for aortic dissection, and retrograde type A dissection has been seen in 4%. We hypothesized that the rigidity of the stent graft could be responsible for these complications. We developed a mathematical lumped parameter model to evaluate this.
Methods: The main objective of this work was to investigate whether one fundamental cause of SINE dissections is an increase in internal blood pressure with the incorporation of a rigid stent graft into the native aorta by using a lumped-parameter model. The interaction between the blood pressure wave and the aortic wall was the major consideration. The aorta was modeled as a compliant tube with variable compliance between the native tissue and the stent graft.
Results: A lumped-parameter model predicted an increase in peak pressure for patients with a rigid stent graft (Fig 1) . The lumped-parameter model predicted an increase in peak pressure for patients with a longer rigid stent graft and compared to patients with a shorter rigid stent graft (Fig 2) .
Conclusions: The model showed an increase in peak pressure after stent graft implantation in the proximal native aorta. This is exacerbated with increased graft length. Further investigation, using a computational finite-element model, is in progress to determine how much local pressure rise is significant and whether larger pressure shifts would occur given the complexity of aortic blood flow. An increase in stent-graft length increases proximal native aorta pressure: patient with rigid stent graft (purple), patient with longer rigid stent graft (green), and patient with a shorter rigid stent graft (blue).
